80930 Federal Register / Vol. 89, No. 193 / Friday, October 4, 2024 / Notices 

submit to the Commission on or before 

5:15 p.m. on October 24, 2024, a written 

brief containing information and 

arguments pertinent to the subject 

matter of the investigations. Parties shall 

file written testimony and 

supplementary material in connection 

with their presentation at the conference 

no later than noon on October 18, 2024. 

All written submissions must conform 

with the provisions of § 201.8 of the 

Commission’s rules; any submissions 

that contain BPI must also conform with 

the requirements of §§ 201.6, 207.3, and 

207.7 of the Commission’s rules. The 

Commission’s Handbook on Filing 

Procedures, available on the 

Commission’s website at https://

www.usitc.gov/documents/handbook_

on_filing_procedures.pdf, elaborates 

upon the Commission’s procedures with 

respect to filings. 

In accordance with §§ 201.16(c) and 

207.3 of the rules, each document filed 

by a party to the investigations must be 

served on all other parties to the 

investigations (as identified by either 

the public or BPI service list), and a 

certificate of service must be timely 

filed. The Secretary will not accept a 

document for filing without a certificate 

of service. 

Certification.—Pursuant to § 207.3 of 

the Commission’s rules, any person 

submitting information to the 

Commission in connection with these 

investigations must certify that the 

information is accurate and complete to 

the best of the submitter’s knowledge. In 

making the certification, the submitter 

will acknowledge that any information 

that it submits to the Commission 

during these investigations may be 

disclosed to and used: (i) by the 

Commission, its employees and Offices, 

and contract personnel (a) for 

developing or maintaining the records 

of these or related investigations or 

reviews, or (b) in internal investigations, 

audits, reviews, and evaluations relating 

to the programs, personnel, and 

operations of the Commission including 

under 5 U.S.C. Appendix 3; or (ii) by 

U.S. government employees and 

contract personnel, solely for 

cybersecurity purposes. All contract 

personnel will sign appropriate 

nondisclosure agreements. 

Authority: These investigations are 

being conducted under authority of title 

VII of the Tariff Act of 1930; this notice 

is published pursuant to § 207.12 of the 

Commission’s rules. 

By order of the Commission. 

Issued: September 30, 2024. 

Lisa Barton, 

Secretary to the Commission. 

[FR Doc. 2024–22956 Filed 10–3–24; 8:45 am] 

BILLING CODE 7020–02–P 

INTERNATIONAL TRADE 

COMMISSION 

[Investigation No. 337–TA–1364] 

Certain Blood Flow Restriction Devices 

With Rotatable Windlasses and 

Components Thereof; Notice of 

Issuance of a General Exclusion Order, 

a Limited Exclusion Order, and Cease 

and Desist Orders; Termination of the 

Investigation 

AGENCY: U.S. International Trade 

Commission. 

ACTION: Notice. 

SUMMARY: Notice is hereby given that 

the U.S. International Trade 

Commission (‘‘Commission’’) has 

determined to issue a general exclusion 

order (‘‘GEO’’) prohibiting the 

importation of blood flow restriction 

devices with rotatable windlasses and 

components thereof that infringe one or 

more of claims 1, 4, 15, or 16 of U.S. 

Patent No. 7,842,067 (‘‘the ’067 patent’’); 

a limited exclusion order (‘‘LEO’’) 

prohibiting the unlicensed entry of 

blood flow restriction devices with 

rotatable windlasses and components 

thereof that infringe the asserted 

trademarks and trade dress that are 

manufactured by or on behalf of, or 

imported by or on behalf of defaulting 

respondents; and cease and desist 

orders (‘‘CDOs’’) directed against certain 

defaulting respondents. The 

investigation is terminated. 

FOR FURTHER INFORMATION CONTACT: 

Joelle P. Justus, Esq., Office of the 

General Counsel, U.S. International 

Trade Commission, 500 E Street SW, 

Washington, DC 20436, telephone (202) 

205–2593. Copies of non-confidential 

documents filed in connection with this 

investigation may be viewed on the 

Commission’s electronic docket (EDIS) 

at https://edis.usitc.gov. For help 

accessing EDIS, please email 

EDIS3Help@usitc.gov. General 

information concerning the Commission 

may also be obtained by accessing its 

internet server at https://www.usitc.gov. 

Hearing-impaired persons are advised 

that information on this matter can be 

obtained by contacting the 

Commission’s TDD terminal on (202) 

205–1810. 

SUPPLEMENTARY INFORMATION: The 

Commission instituted this investigation 

on May 31, 2023, based on a complaint, 

as supplemented, filed by Composite 

Resources, Inc. of Rock Hill, South 

Carolina, and North American Rescue, 

LLC of Greer, South Carolina 

(collectively, ‘‘Complainants’’). 88 FR 

34893–95 (May 31, 2023). The 

complaint, as supplemented, alleged 

violations of section 337 of the Tariff 

Act of 1930, as amended, 19 U.S.C. 

1337, in the importation into the United 

States, sale for importation, or sale in 

the United States after importation of 

certain blood flow restriction devices 

with rotatable windlasses and 

components thereof that infringe one or 

more of: claims 1–17 of the ’067 patent, 

claims 1–30 of the U.S. Patent No. 

8,888,807 (‘‘the ’807 patent’’), and 

claims 1–13 of the U.S. Patent No. 

10,016,203 (‘‘the ’203 patent’’); United 

States Trademark Registration Nos. 

3,863,064 and 5,064,378; and trade 

dress infringement in violation of 

Section 43(a) of the Lanham Act (15 

U.S.C. 1125) the threat or effect of 

which is to destroy or substantially 

injure an industry in the United States. 

Id. at 34893–94; see Complaint, ¶¶ 9–15. 

The complaint also requested the 

issuance of a GEO with respect to all of 

these allegations. 

The Commission’s notice of 

investigation named the following 

respondents: (1) Anping Longji Medical 

Equipment Factory of Hengshui City, 

China; Dongguanwin Si Hai Precision 

Mold Co., Ltd. of Dongguan, China; 

Eiffel Medical Supplies Co., Ltd. of 

Shenzhen, China; Empire State 

Distributors Inc. of Brooklyn, New York; 

EMRN Medical Equipment of LaSalle, 

Canada; GD Tianwu New Material Tech 

Co., Ltd. of Shawan Town, China; 

Hengshui Runde Medical Instruments 

Co., Ltd. of Hengshui City, China; 

Putian Dima Trading Co., Ltd. of Putian 

City, China; Rhino Inc. of Lewes, 

Delaware; Shanghai Sixu International 

Freight Agent Co., Ltd. of Shanghai, 

China; Shenzhen Anben E-Commerce 

Co., Ltd. of Shenzhen, China; Shenzhen 

TMI Medical Supplies Co., Ltd. of 

Shenzhen, China; Shenzhen Yujie 

Commercial and Trading Co., Ltd. of 

Shenzhen, China; Wuxi Emsrun 

Technology Co., Ltd. of Wuxi City, 

China; Wuxi Golden Hour Medical 

Technology Co., Ltd. of Wuxi City, 

China; and Wuxi Puneda Technology 

Co., Ltd. of Wuxi City, China 

(collectively, ‘‘the Defaulting 

Respondents’’); (2) Chaozhou Jiduo 

Trading Co., Ltd. of Chaozhou City, 

China; Dongguan Hongsui Electronic 

Commerce, Co., Ltd. of Dongguan City, 

China; Fuzhou Meirun Medical 

Equipment Technology Co., Ltd. of 

Fuzhou, China; Henan Eyocean EVerDate Sep<11>2014 17:26 Oct 03, 2024 Jkt 265001 PO 00000 Frm 00076 Fmt 4703 Sfmt 4703 E:\FR\FM\04OCN1.SGM 04OCN1

khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 89, No. 193 / Friday, October 4, 2024 / Notices 80931 

Commerce Co., Ltd. of Zhengzhou, 

China; Huang Xia of Sangzi Town, 

China; Jingcai Jiang of Shenzhen, China; 

Shen Yi of Shenzhen, China; Shenzhen 

Janxle E E Commerce Co., Ltd. of 

Shenzhen, China; Shenzhen Smart 

Medical Co. Ltd. of Shenzhen, China; 

Sun Minghui of Shenzhen, China; Xia 

Guo Long of Dongguan City, China; and 

Yinping Yin of Shenzhen, China 

(collectively, ‘‘the Unserved 

Respondents’’); and (3) Express 

Companies, Inc. of Oceanside, 

California, and SZY Holdings LLC of 

Brooklyn, New York (collectively, ‘‘the 

Participating Respondents’’). Id. The 

Office of Unfair Import Investigations 

(‘‘OUII’’) is also a party to this 

investigation. 

The Commission terminated the 

Participating Respondents based on the 

entry of consent orders. See Order No. 

7 (Aug. 9, 2023), unreviewed by Comm’n 

Notice (Sept. 5, 2023); Order No. 13 

(Oct. 3, 2023), unreviewed by Comm’n 

Notice (Nov. 2, 2023). The Commission 

also terminated the Unserved 

Respondents based on the withdrawal of 

the complaint as to those respondents. 

See Order No. 10 (Aug. 22, 2023), 

unreviewed by Comm’n Notice (Sept. 

20, 2023). The Commission also found 

the Defaulting Respondents in default. 

See Order No. 11 (Aug. 29, 2023), 

unreviewed by Comm’n Notice (Sept. 

22, 2023). 

On November 1, 2023, Complainants 

filed a motion to partially terminate the 

investigation with respect to the ’807 

and ’203 patents. On November 2, 2023, 

the ALJ issued Order No. 14 granting the 

motion. Order No. 14 (Nov. 2, 2023), 

unreviewed by Comm’n Notice (Dec. 4, 

2023). On January 23, 2024, 

Complainants filed a motion to 

terminate claims 2, 3, 5–14, and 17 of 

the ’067 patent. On January 25, 2024, 

the ALJ issued Order No. 19 granting the 

motion. Order No. 19 (Jan. 25, 2024), 

unreviewed by Comm’n Notice (Feb. 15, 

2024). Therefore, only claims 1, 4, 15, 

and 16 of the ’067 patent remained 

asserted. 

On December 22, 2023, Complainants 

filed a motion for summary 

determination on violation of section 

337 with regard to the ’067 patent, 

asserted trademarks, and asserted trade 

dress by the Defaulting Respondents. On 

February 7, 2024, the ALJ issued Order 

No. 20, granting the motion in part with 

respect to the claims 1, 4, 15, and 16 of 

the ’067 patent. Order No. 20 (Feb. 7, 

2024), unreviewed by Comm’n Notice 

(Mar. 6, 2024). Order No. 20 found that 

(1) the importation requirement was 

satisfied with respect to the Defaulting 

Respondents with the exception of 

Empire State Distributors Inc.; (2) the 

accused products infringe claims 1, 4, 

15, and 16 of the ’067 patent; (3) the 

domestic industry products practice 

claim 1 of the ’067 patent; and (4) the 

economic prong of the domestic 

industry was satisfied. Id. The 

Commission determined not to review 

the affirmative findings in Order No. 20. 

See Comm’n Notice (Mar. 6, 2024). 

On March 1, 2024, Complainants filed 

a motion to terminate the investigation 

in part based on a withdrawal of its 

request for a GEO as to the trademark 

and trade dress claims and to cancel the 

evidentiary hearing. On March 19, 2024, 

the ALJ granted the motion and issued 

Order No. 23, which was styled as an 

initial determination. The Commission 

determined that the request to withdraw 

a requested remedy is not properly the 

subject of a motion for termination nor 

an issue that must be decided in the 

form of an initial determination. 

Comm’n Notice at 3 (April 18, 2024). 

Accordingly, the Commission treated 

Order No. 23 as an order and not an 

initial determination. Id. 

Order No. 23 also included the ALJ’s 

Recommended Determination (‘‘RD’’) on 

remedy and bonding. Specifically, the 

RD recommended that the Commission 

issue a GEO as to claims 1, 4, 15, and 

16 of the ’067 patent. RD at 9–12. The 

RD further recommended issuing an 

LEO as well as CDOs against each of the 

Defaulting Respondents in connection 

with the patent, trademark, and trade 

dress claims. Id. at 13–15. Finally, the 

RD recommended that the Commission 

set the bond during the Presidential 

review period at one hundred percent 

(100%). Id. at 15–16. 

The Commission issued a notice 

soliciting comments regarding any 

public interest concerns raised by the 

recommend relief appeared in the 

Federal Register on April 2, 2024. See 

89 FR 22741 (Apr. 2, 2024). 

Complainants filed a statement on 

public interest pursuant to Commission 

Rule 210.50(a)(4), 19 CFR 210.50(a)(4), 

but no other comments were received in 

response to the notice. 

The Commission requested briefing 

on remedy, bonding, and the public 

interest. Comm’n Notice (Apr. 18, 2024); 

89 FR 31214–6 (Apr. 24, 2024). On May 

2, 2024, Complainants and OUII filed 

opening submissions. On May 16, 2024, 

Complainants and OUII filed responsive 

submissions. No other party filed a 

submission before the Commission. 

Having reviewed the record of the 

investigation, including the RD and the 

parties’ submissions, the Commission 

has determined that the appropriate 

remedy is: (1) a GEO prohibiting the 

unlicensed entry of blood flow 

restriction devices with rotatable 

windlasses and components thereof that 

infringe one or more of claims 1, 4, 15, 

and/or 16 of the ’067 patent; (2) an LEO 

prohibiting the unlicensed entry of 

blood flow restriction devices with 

rotatable windlasses and components 

thereof that infringe the asserted 

trademarks and/or the asserted trade 

dress manufactured by or on behalf of, 

or imported by or on behalf of any of the 

Defaulting Respondents; and (3) CDOs 

directed against Anping Longji Medical 

Equipment Factory; Empire State 

Distributors Inc.; Hengshui Runde 

Medical Instruments Co., Ltd.; Putian 

Dima Trading Co., Ltd.; Rhino Inc.; 

Shenzhen Anben E-Commerce Co., Ltd.; 

Shenzhen Yujie Commercial and 

Trading Co., Ltd.; Wuxi Emsrun 

Technology Co., Ltd.; and Wuxi Puneda 

Technology Co., Ltd. 

The Commission has further 

determined that the public interest 

factors enumerated in subsections (d)(l), 

(f)(1), and (g)(1) (19 U.S.C. 1337(d)(l), 

(f)(1), (g)(1)) do not preclude issuance of 

the above referenced remedial orders. 

Additionally, the Commission has 

determined to impose a bond of 100% 

of entered value of the covered products 

during the period of Presidential review 

(19 U.S.C. 1337(j)). 

This investigation is terminated. 

The Commission vote for this 

determination took place on September 

30, 2024. 

This action is taken under the 

authority of section 337 of the Tariff Act 

of 1930, as amended (19 U.S.C. 1337), 

and in part 210 of the Commission’s 

Rules of Practice and Procedure (19 CFR 

part 210). 

By order of the Commission. 

Issued: September 30, 2024. 

Lisa Barton, 

Secretary to the Commission. 

[FR Doc. 2024–22937 Filed 10–3–24; 8:45 am] 

BILLING CODE 7020–02–P 

DEPARTMENT OF JUSTICE 

[OMB 1140–0031] 

Agency Information Collection 

Activities; Proposed eCollection 

eComments Requested; Revision of a 

Previously Approved Collection; 

Records of Acquisition and 

Disposition by Registered Importers of 

Arms, Ammunition, and Defense 

Articles on the U.S. Munitions Import 

List 

AGENCY: Bureau of Alcohol, Tobacco, 

Firearms, and Explosives, Department of 

Justice. 

ACTION: 60-Day notice. 


khammond on DSKJM1Z7X2PROD with NOTICES